Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis

Huseyin Bozbas1, Aylin Yildirir, Ozlem Demir

  • 1Baskent University, Faculty of Medicine, Department of Cardiology, Ankara, Turkey. hbozbas@gmail.com

Insights

Serum gamma-glutamyltransferase (GGT) is elevated in patients with calcific aortic stenosis (AS), indicating increased oxidative stress. This elevation appears more pronounced in advanced stages of calcific aortic valve disease.

Area of Science:

  • Cardiology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Serum gamma-glutamyltransferase (GGT) activity is linked to oxidative stress and cardiovascular diseases.
  • Calcific aortic valve disease shares characteristics with atherosclerosis.
  • The role of GGT in calcific aortic valve disease requires further investigation.

Purpose of the Study:

  • To investigate the association between serum GGT activity and calcific aortic valve disease.
  • To compare GGT levels in patients with aortic stenosis (AS) and aortic valve calcification (AVC) against controls.

Main Methods:

  • Retrospective analysis of echocardiography data from 383 patients (AS, AVC, and controls).
  • Serum GGT activity and other liver enzymes were measured and compared across groups.
  • Age- and gender-matched controls with normal aortic valve morphology were selected.

Main Results:

  • Serum GGT levels were significantly higher in AS patients compared to controls (median 23.0 U/L vs. 18.0 U/L).
  • Patients with AVC did not show significantly different GGT levels compared to controls.
  • Elevated C-reactive protein was also observed in AS patients.

Conclusions:

  • Serum GGT activity is increased in patients with calcific aortic stenosis.
  • Elevated GGT may indicate more advanced stages of calcific aortic valve disease.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...